Clinical Trials Browser

Phase 2 × Fenretinide × Thoracic × Clear all

NCT00009971 2013-02-11

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma